Renowned Biopharma Leaders Join Newly Established Kallyope Clinical Development Advisory Board

NEW YORK--(BUSINESS WIRE)--Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the formation of its inaugural Clinical Development Advisory Board. The board is composed of four distinguished physicians and scientists who wil...

Related Keywords

New York ,United States ,Alexandria Center ,Thomas Koestler ,Tom Maniatis ,Jeffrey Chodakewitz ,Charles Zuker ,Elizabeth Stoner ,Bristol Myers Squibb ,Bausch Lomb ,Jay Galeota ,Scott Korn ,Richard Axel ,Schering ,Vascular Pharmaceuticals ,Clinical Development Advisory Board ,Schering Corporation ,Edgemont Pharmaceuticals ,Novartis Pharmaceuticals ,Kallyope Inc ,Merck Research Laboratories ,Innovation At Vertex Pharmaceuticals ,Momenta Pharmaceuticals ,Drug Administration ,Westwood Pharmaceuticals ,Rhythm Pharmaceuticals ,Plough Research Institute ,Kallyope Clinical Development Advisory Board ,European Medicines Agency ,Sandoz Pharmaceuticals ,Global Regulatory Affairs ,Novo Nordisk ,Clinical Development Advisory ,Clinical Medicine ,External Innovation ,Vertex Pharmaceuticals ,Schering Plough Research Institute ,Ortho Mcneil ,Scientific Advisory Board ,Melinta Therapeutics ,United States Food ,Semma Therapeutics ,Global Clinical Development Operations ,Life Science ,New York City ,Lasker Award ,